Effects of an Aerobic Exercise Protocol Combined with Systemic Photobiomodulation on Pain, Cardiorespiratory Fitness and Functional Capacity in Women with Fibromyalgia: A Randomized, Blinded Clinical Trial
This randomized, blinded clinical trial found that a 12-week aerobic exercise program significantly improved functional capacity, quality of life, and pressure pain thresholds in women with fibromyalgia, while the addition of active systemic photobiomodulation (ILIB) provided no consistent advantage over placebo except for a greater reduction in pain intensity.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Fibromyalgia is a condition that turns the body's pain signals into a constant, widespread alarm. People living with it experience deep, aching pain in muscles and joints that seems to come from everywhere at once, often accompanied by exhaustion that sleep cannot fix and a mind that struggles to focus. Because the pain is so pervasive, many patients find themselves trapped in a difficult cycle: they move less to avoid hurting, which makes their muscles weaker and their bodies less fit, which in turn makes even small movements feel more painful. While doctors often prescribe medication to manage the symptoms, there is a growing recognition that moving the body is one of the most powerful tools available to break this cycle. Exercise helps retrain the nervous system to handle pain better and improves the body's ability to use oxygen, yet for many, the very act of starting can feel impossible due to the fear of triggering a flare-up. This has led researchers to look for ways to make exercise easier to tolerate, exploring whether adding light-based therapies could act as a gentle bridge, helping patients get the benefits of movement without the usual spike in suffering.
In a recent study conducted at the Federal University of São Paulo, a team of researchers set out to test exactly this idea. They recruited seventy-five women who had been diagnosed with fibromyalgia and divided them into three groups to see how different combinations of treatments would affect their pain, their ability to walk, and their overall quality of life. One group performed a standard aerobic exercise program on stationary bicycles twice a week for twelve weeks while receiving a real, active treatment of light therapy applied to their wrists. A second group did the exact same exercise routine but received a fake version of the light therapy, where the device looked and felt the same but did not emit any light. The third group served as a control, meaning they did not exercise or receive any light therapy during the study period, simply waiting to be tested at the beginning and the end. The goal was to see if the active light therapy, known as intravascular laser irradiation of blood, could boost the benefits of the exercise beyond what the exercise could achieve on its own.
The results showed that the women who exercised, regardless of whether they received the real light or the fake light, made significant progress in several key areas. Both exercise groups were able to walk farther in six minutes by the end of the study compared to the women who did not exercise, indicating a clear improvement in their functional capacity. They also reported that their daily lives were less disrupted by the disease, with better scores on measures of physical function and emotional well-being. Perhaps most notably, the women who exercised saw an increase in their pressure pain threshold, meaning they could withstand more pressure on their muscles before feeling pain. This suggests that the simple act of moving the body helped calm the overactive pain signals that characterize fibromyalgia.
However, when the researchers looked closely at the difference between the group that received the real light and the group that received the fake light, the picture became more nuanced. The women who received the active light therapy alongside their exercise reported a greater reduction in their overall pain intensity compared to the other groups. They noted that their pain at rest and their worst pain from the previous week dropped more significantly, reaching a level of improvement that is considered clinically meaningful for patients. Despite this specific advantage in pain relief, the active light therapy did not provide any extra boost to their walking distance or their overall quality of life scores compared to the group that only exercised. Furthermore, neither group saw a measurable improvement in their maximum cardiorespiratory fitness, which is a measure of how efficiently the heart and lungs work during intense effort. This suggests that while the light therapy may have helped soothe the pain enough to make the exercise feel better, it did not fundamentally change the body's physical engine in the way that longer or more intense training might.
The study concludes that aerobic exercise remains the most powerful tool for improving function and quality of life for women with fibromyalgia, acting as the primary driver of recovery. The addition of the light therapy offered a promising, though limited, benefit specifically for pain reduction, hinting that it might help patients tolerate exercise better or feel less pain during their daily activities. The researchers caution that while the combination looks encouraging, the light therapy did not consistently outperform the placebo in most areas, and the specific settings used for the light treatment may need further refinement. Ultimately, the findings reinforce the value of non-drug approaches to managing this complex condition, showing that movement is essential, and that while light therapy might offer a helpful hand in managing pain, it is the exercise itself that carries the weight of the recovery.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.